BMYMP - Bristol-Myers Squibb Co (BMY) Presents at Barclays Global Healthcare Broker Conference Call - (Transcript)

Bristol-Myers Squibb Co (BMY) Barclays Global Healthcare Conference March 16, 2022, 13:35 ET Company Participants Samit Hirawat - EVP & Chief Medical Officer, Global Drug Development Conference Call Participants Carter Gould - Barclays Bank Presentation Carter Gould Good afternoon, and welcome to the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays. Welcome. And next up is Bristol-Myers Squibb. We're really happy to have Bristol here, again, one of these companies that we've been looking forward to meet in person over the past 2 years. And joining from the company is the CMO and Head of Global Drug Development, Samit Hirawat. Samit, thank you very much for joining us today. Samit Hirawat Thank you, Carter. Pleasure. Question-and-Answer Session Q - Carter Gould And in contrast to many of your peers, you have a very active 2022 from a catalyst perspective. A lot of clinical

For further details see:

Bristol-Myers Squibb Co (BMY) Presents at Barclays Global Healthcare Broker Conference Call - (Transcript)